Targeting interleukin (IL)-4/IL-13 in immune checkpoint inhibitor-induced bullous pemphigoid: a cautionary note on the beneficial effect of T helper 2 immunity in melanoma and immunotherapy: reply from the authors

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of dermatology (1951) 2023-12, Vol.190 (1), p.138-138
Hauptverfasser:	Shipman, William D, Singh, Katelyn, Cohen, Jeffery M, Leventhal, Jonathan, Damsky, William, Tomayko, Mary M
Format:	Artikel
Sprache:	eng
Schlagworte:	Humans Immune Checkpoint Inhibitors - therapeutic use Immunotherapy - adverse effects Interleukin-13 Interleukins Melanoma - drug therapy Pemphigoid, Bullous - chemically induced Pemphigoid, Bullous - drug therapy Pemphigoid, Bullous - immunology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!